AsOf

Recorded or changed on this day 2026-11-08

701–750 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 6,432,000,000 United States dollar
AbbVie quarterly operating income: 6,432,000,000 United States dollar, claim clm_67BFBB091A03 · ended · superseded by clm_5AF8A08D6F94 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 32,753,000,000 United States dollar
AbbVie revenue: 32,753,000,000 United States dollar, claim clm_67CC49EA52CC · ended · superseded by clm_EB4D7B27A2A8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 4,717,000,000 United States dollar
AbbVie quarterly operating income: 4,717,000,000 United States dollar, claim clm_68DCF1A8E9E3 · ended · superseded by clm_9573F19B5964 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -8,446,000,000 United States dollar
AbbVie total equity: -8,446,000,000 United States dollar, claim clm_690948A561DC · ended · superseded by clm_1101E4339729 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,305,000,000 United States dollar
AbbVie quarterly operating income: 1,305,000,000 United States dollar, claim clm_69DD4A7597DD · ended · superseded by clm_ABFEE686F09F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -3,270,000,000 United States dollar
AbbVie total equity: -3,270,000,000 United States dollar, claim clm_6A970AB08DB3 · ended · superseded by clm_86F602E30464 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 41,000,000 United States dollar
AbbVie cash and equivalents: 41,000,000 United States dollar, claim clm_6BE76CD99628 · ended · superseded by clm_8AB294800E36 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,765,046,680 shares
AbbVie shares outstanding: 1,765,046,680 shares, claim clm_6CE3680212C4 · ended · superseded by clm_A6F2CE4E7D05 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 150,565,000,000 United States dollar
AbbVie total assets: 150,565,000,000 United States dollar, claim clm_6E0C0CFE3683 · ended · superseded by clm_9715BC353D4D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 3,547,000,000 United States dollar
AbbVie cash and equivalents: 3,547,000,000 United States dollar, claim clm_6E84A216F14F · ended · superseded by clm_8F6D833F6BDE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,467,000,000 United States dollar
AbbVie cash and equivalents: 6,467,000,000 United States dollar, claim clm_6EBD1BCE1675 · ended · superseded by clm_E498EA77B417 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 4,863,000,000 United States dollar
AbbVie total equity: 4,863,000,000 United States dollar, claim clm_6F0CD2AA2AA9 · ended · superseded by clm_6F4282E76FED · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 3,945,000,000 United States dollar
AbbVie total equity: 3,945,000,000 United States dollar, claim clm_6F4282E76FED · ended · superseded by clm_1C685783785E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,476,742,215 shares
AbbVie shares outstanding: 1,476,742,215 shares, claim clm_6FF261038A02 · ended · superseded by clm_BBC4CE8C1A41 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 14,462,000,000 United States dollar
AbbVie quarterly revenue: 14,462,000,000 United States dollar, claim clm_702A9C257ED5 · ended · superseded by clm_1DE14AF1FBB3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 4,645,000,000 United States dollar
AbbVie total equity: 4,645,000,000 United States dollar, claim clm_70ABDD4E760D · ended · superseded by clm_1D6156E5BADB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 3,553,000,000 United States dollar
AbbVie quarterly net income: 3,553,000,000 United States dollar, claim clm_712B18F8C713 · ended · superseded by clm_8C62E1009F26 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 9,137,000,000 United States dollar
AbbVie operating income: 9,137,000,000 United States dollar, claim clm_7198B453007F · ended · superseded by clm_D4AF640165D7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 11,363,000,000 United States dollar
AbbVie operating income: 11,363,000,000 United States dollar, claim clm_741BF6260BB0 · ended · superseded by clm_312A48E2B5D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,419,000,000 United States dollar
AbbVie quarterly operating income: 2,419,000,000 United States dollar, claim clm_7516913F42F9 · ended · superseded by clm_504B0BC83B6A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 15,776,000,000 United States dollar
AbbVie quarterly revenue: 15,776,000,000 United States dollar, claim clm_7673BF825A9D · ended · superseded by clm_2A1D46B6132E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 4,441,000,000 United States dollar
AbbVie quarterly operating income: 4,441,000,000 United States dollar, claim clm_76F20660B779 · ended · superseded by clm_A6866F9C10EF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 22,859,000,000 United States dollar
AbbVie revenue: 22,859,000,000 United States dollar, claim clm_778004ECC385 · ended · superseded by clm_B8A18C367510 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,351,000,000 United States dollar
AbbVie quarterly operating income: 1,351,000,000 United States dollar, claim clm_781C2FB5DFBA · ended · superseded by clm_F8769037DF45 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,399,000,000 United States dollar
AbbVie cash and equivalents: 8,399,000,000 United States dollar, claim clm_78885045199F · ended · superseded by clm_FC08DA3650E9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,990,000,000 United States dollar
AbbVie quarterly operating income: 3,990,000,000 United States dollar, claim clm_78F42A193166 · ended · superseded by clm_67BFBB091A03 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · registrant name · AbbVie Inc.
AbbVie registrant name: AbbVie Inc., claim clm_78F47A4D8706 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 239,000,000 United States dollar
AbbVie quarterly net income: 239,000,000 United States dollar, claim clm_78FB737BE749 · ended · superseded by clm_5E66D98A66E7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,218,000,000 United States dollar
AbbVie cash and equivalents: 6,218,000,000 United States dollar, claim clm_79527B6A026A · ended · superseded by clm_CFE5A45B27A0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 17,254,000,000 United States dollar
AbbVie total equity: 17,254,000,000 United States dollar, claim clm_79A5901E7AEB · ended · superseded by clm_A6146EA9ECE9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 741,000,000 United States dollar
AbbVie quarterly net income: 741,000,000 United States dollar, claim clm_7A765E3288C2 · ended · superseded by clm_AEBAD82024FE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 29,198,000,000 United States dollar
AbbVie total assets: 29,198,000,000 United States dollar, claim clm_7B4C916FCBA1 · ended · superseded by clm_97E99E151E53 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 7,828,000,000 United States dollar
AbbVie quarterly revenue: 7,828,000,000 United States dollar, claim clm_7B8BB25C6DC4 · ended · superseded by clm_13C8A0924EB0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,766,792,821 shares
AbbVie shares outstanding: 1,766,792,821 shares, claim clm_7C1384CB0CC0 · ended · superseded by clm_86C65743AE05 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 1,286,000,000 United States dollar
AbbVie quarterly net income: 1,286,000,000 United States dollar, claim clm_7C59982F22F4 · ended · superseded by clm_BC27B55DAB48 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 18,380,000,000 United States dollar
AbbVie revenue: 18,380,000,000 United States dollar, claim clm_7D34A43B5B1E · ended · superseded by clm_10EA1069A66F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 14,342,000,000 United States dollar
AbbVie quarterly revenue: 14,342,000,000 United States dollar, claim clm_7EFD9B1EE312 · ended · superseded by clm_020CA528788D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,593,886,909 shares
AbbVie shares outstanding: 1,593,886,909 shares, claim clm_7FD76082DBAA · ended · superseded by clm_1A9033C7E5CD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 39,924,000,000 United States dollar
AbbVie cash and equivalents: 39,924,000,000 United States dollar, claim clm_80A654D2EDD2 · ended · superseded by clm_39876A48A684 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 18,117,000,000 United States dollar
AbbVie operating income: 18,117,000,000 United States dollar, claim clm_810E9C4E1BC6 · ended · superseded by clm_5D66F3208260 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 27,910,000,000 United States dollar
AbbVie total assets: 27,910,000,000 United States dollar, claim clm_81724D6111B8 · ended · superseded by clm_D47B65E8AFA3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 13,343,000,000 United States dollar
AbbVie quarterly revenue: 13,343,000,000 United States dollar, claim clm_8213D3858DF4 · ended · superseded by clm_83F895DA4455 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,733,000,000 United States dollar
AbbVie quarterly operating income: 3,733,000,000 United States dollar, claim clm_837AACDD66BC · ended · superseded by clm_BA8EDB44AFDD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 15,423,000,000 United States dollar
AbbVie quarterly revenue: 15,423,000,000 United States dollar, claim clm_83F895DA4455 · ended · superseded by clm_7673BF825A9D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,371,000,000 United States dollar
AbbVie quarterly operating income: 1,371,000,000 United States dollar, claim clm_852AC8B3FCCC · ended · superseded by clm_781C2FB5DFBA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,798,000,000 United States dollar
AbbVie quarterly operating income: 2,798,000,000 United States dollar, claim clm_854E200D3C92 · ended · superseded by clm_9B48C67E536A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,767,117,285 shares
AbbVie shares outstanding: 1,767,117,285 shares, claim clm_86C65743AE05 · ended · superseded by clm_54135339A00E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -6,656,000,000 United States dollar
AbbVie total equity: -6,656,000,000 United States dollar, claim clm_86F602E30464 · ended · superseded by clm_00E837EDC859 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 13,710,000,000 United States dollar
AbbVie total equity: 13,710,000,000 United States dollar, claim clm_875E4AB51928 · ended · superseded by clm_EEA6EF5889A9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 695,000,000 United States dollar
AbbVie quarterly net income: 695,000,000 United States dollar, claim clm_879DEDC1ACEA · ended · superseded by clm_A0327C4F8772 · 1 source (1 primary) · conf 0.95

What the statuses mean